No abstract available.
Female ; Ovarian Hyperstimulation Syndrome*

The authors studied in two years on 296 cycles of induced ovulation. The ovarian hyperstimulation syndrome (OHSS) was occurred in 14, 19% of total cycles, in which there are 4,05% of severe OHSS. The rate of pregnancy is 41% of OHSS, instead of 30% of induced ovulation cycles with HMG-HCG. The prevention of OHSS is strictly controlled basing on the monitoring of the function of ovary when induced ovulation with HMG-HCG by serum E2 analysis and follicle diameter measurement with sonography. The HCG after HMG is eliminated when appeared OHSS odd degree I is occurred; and the infusion of serum in case of OHSS of degree III could interrupt the progress of more severe OHSS, and bring the patient to the normal situation.
Ovarian Hyperstimulation Syndrome ; Ovulation

Currently, the infertile treatment and ovarian stimulation are increasingly which leads an increase of ovarian hyperstimulation syndrome. The patients with ovarian hyperstimulation syndrome can be examined and treated in any health facilities. However, most of health staffs have not thoroughly known or had experiences in the management of ovarian hyperstimulation syndrome. By knowing the risk factor, symptoms and management will help the health staff managing properly and safely the ovarian hyperstimulation syndrome
Ovarian Hyperstimulation Syndrome ; Safety

No abstract available.
Basilar Artery ; Female ; Ovarian Hyperstimulation Syndrome

No abstract available.
Female ; Ovarian Hyperstimulation Syndrome* ; Ovulation Induction* ; Ovulation*

Objective: To compare the efficacy of Letrozole and Gonadotropin, given alone or in combination, in controlled ovarian hyperstimulation in Clomiphene citrate poor responders. Study Design: Prospective, non-randomized observational study on Clomiphene citrate poor responders at the St. Luke's Medical Center setting from January to July 2006. Results: Letrozole and gonadotropins, whether given alone or in combination, have similar clinical outcomes in terms of endometrial thickness during ovulation and the number of dominant follicles developed. The use of gonadotropins results in 100% ovulation rate, similar to results when Letrozole is used as an adjunct. Letrozole significantly reduces the dose of gonadotropin required to develop a mature follicle. Conclusion: Since the use of Letrozole and gonadotropins for ovarian hyperstimulation had similar results, Letrozole has the advantage of reduced cost and greater patient acceptance. It may be used alone or in conjunction with gonadotropins for poor responders to Clomiphene citrate.
Human ; Female ; OVARIAN HYPERSTIMULATION SYNDROME ; GONADOTROPINS ; LETROZOLE

This is the case of a 26 year-old nulligravida with Polycystic Ovary Syndrome who developed severe Ovarian Hyperstimulation Syndrome (OHSS) during ovulation induction for Intrauterine Insemination (IUI). Three problems were encountered during treatment. The first was whether to convert a planned ovulation induction and IUI, that resulted in multiple follicular development, to an in vitro Fertilization - Intracytoplasmic Sperm Injection cycle. The second problem was determining what strategies are relevant in preventing OHSS in a woman at high risk for developing severe hyperstimulation. The third problem was why, when and how to employ abdominal paracentesis in the management of severe OHSS. Though the patient's course was turbulent, management was successful. She is now awaiting embryo transfer and, ultimately, motherhood.
Human ; Female ; Adult ; OVARIAN HYPERSTIMULATION SYNDROME ; POLYCYSTIC OVARY SYNDROME

No abstract available.
Angiotensin II* ; Angiotensins* ; Capillary Permeability ; Female ; Ovarian Hyperstimulation Syndrome

No abstract available.
Female ; Female* ; Humans ; Hypothyroidism* ; Lingual Thyroid* ; Ovarian Hyperstimulation Syndrome*

No abstract available.
Female ; Female* ; Humans ; Hypothyroidism* ; Lingual Thyroid* ; Ovarian Hyperstimulation Syndrome*